Mohs vs Plastic Surgery

Do Mohs Surgeons or Plastic Surgeons Perform Better Facial Reconstruction After Skin Cancer Removal?

Mohs micrographic surgeons perform approximately 75% of all facial reconstructive procedures in the United States and achieve infection rates five to eight times lower than hospital-based surgery. According to Dr. Thomas L. Hocker, M.D., M.Phil., a triple board-certified Mohs surgeon at Advanced Dermatologic Surgery, a national referral center for melanoma and high-risk skin cancer in Overland Park, Kansas, surgical outcomes are driven primarily by procedure volume rather than specialty title. Mohs surgeons perform facial repairs daily, often completing 10–15 facial reconstructions per day.


This analysis reviews Medicare data, infection rate studies, and blinded cosmetic outcome trials to address a common patient question:

Should facial reconstruction be performed by the Mohs surgeon, or should patients be referred to a plastic surgeon?

Who This Article Is For

  • Patients diagnosed with facial skin cancer who are evaluating reconstruction options
  • Individuals seeking to understand differences between Mohs and plastic surgery reconstruction
  • Referring physicians assessing appropriate reconstruction pathways for their patients

Key Takeaways

  • Mohs surgeons perform 75.3% of all facial reconstructive procedures in cosmetically sensitive areas, based on 2023 Medicare data.
  • Published Mohs surgery infection rates range from 0.7% to 2.0%, depending on anatomic site and risk factors. Hospital-based procedures report infection rates between 2.5% and 8.7%.
  • Advanced Dermatologic Surgery maintains an infection rate of 0.43% by performing reconstructions in an AAAHC-certified ambulatory surgery center under sterile operating room conditions and local anesthesia.
  • Dr. Hocker performs 22 paramedian forehead flaps annually, more than double the volume of most facial plastic surgeons.
  • Blinded studies demonstrate no statistically significant difference in cosmetic outcomes between Mohs surgeons and plastic surgeons for facial reconstruction.
  • Same-day reconstruction by the excising surgeon reduces information loss, lowers wound-care burden, and decreases the total cost of care.
Infographic outlining outcomes, safety, and expertise of Mohs surgeon vs Plastic Surgeon for facial reconstruction.

Who Performs the Majority of Facial Reconstruction in the United States?

A 2023 Medicare analysis found that Mohs surgeons performed 75.3% of all cutaneous reconstructions in cosmetically and functionally sensitive areas, including the face, ears, nose, lips, and eyelids. Earlier Medicare data from 2004–2009 showed dermatologic surgeons accounted for:

  • 75.1% of complex repairs
  • 60.8% of intermediate repairs
  • 55.5% of local tissue rearrangements
  • 57.5% of full-thickness skin grafts

Why Surgical Volume Matters

The volume–outcome relationship is well established in surgical literature. Surgeons who perform procedures more frequently demonstrate lower complication rates, shorter operative times, and greater technical precision. A Mohs surgeon performing 10–15 facial reconstructions per day gains more experience in one month than many surgeons accumulate in an entire year.


The Paramedian Forehead Flap: The Gold Standard for Nasal Reconstruction

The nose is the central focal point of the face, making nasal reconstruction one of the most demanding tasks in facial surgery. The paramedian forehead flap is widely regarded as the gold standard for large or complex nasal defects due to its superior tissue match, vascular reliability, and reconstructive versatility.


A 2024 national survey found that over 60% of facial plastic surgeons perform 10 or fewer forehead flaps annually, while Dr. Hocker performs 22 per year, reflecting his high-volume referral practice for complex skin cancer reconstruction.

Safety: Outpatient Mohs Surgery vs. Hospital-Based Reconstruction

Outpatient Mohs surgery demonstrates significantly lower infection rates than hospital-based reconstruction. Published studies report Mohs surgery infection rates between 0.7% and 2.0%, compared with 2.5% to 8.7% for hospital-based procedures.

At Advanced Dermatologic Surgery, reconstructions are performed in a sterile ambulatory surgery center under local anesthesia, avoiding hospital-acquired organisms and the infection risks associated with general anesthesia. This model supports an exceptionally low infection rate of 0.43%.

Cosmetic Outcomes: Mohs Surgeons vs. Plastic Surgeons

Blinded clinical studies consistently show no statistically significant difference in cosmetic outcomes between Mohs surgeons and plastic surgeons. Scar quality is determined by surgical technique, tissue handling, wound tension management, and patient healing factors—not by specialty designation alone.

Advantages of Same-Surgeon Reconstruction

When the same surgeon performs both cancer removal and reconstruction, continuity of care is preserved. This approach:

  • Eliminates information loss between providers
  • Reduces the need for multiple visits
  • Lowers overall costs
  • Avoids prolonged open wound care

When Referral Is Appropriate

Referral to another specialist may be appropriate for:

  • Extremely large defects
  • Cases requiring bone or cartilage replacement
  • Free tissue transfer
  • Situations requiring general anesthesia
  • Patient preference after informed discussion



These decisions should be based on clinical complexity, not assumptions about specialty superiority.

Thomas Hocker, M.D. is a triple board-certified dermatologist, dermatopathologist, and Mohs micrographic surgeon at Advanced Dermatologic Surgery in Overland Park, Kansas. He graduated from Yale University, where he studied biology, and received a Churchill Fellowship to study organic chemistry at Cambridge University in England. He attended Harvard Medical School, where he conducted melanoma research under Dr. Hensin Tsao, a world leader in melanoma genetics.


Dr. Hocker completed his internship at Santa Clara Valley Medical Center (Stanford-affiliated), followed by dermatology residency at Mayo Clinic. He pursued subspecialty training with a dermatopathology fellowship at the University of Michigan—home to one of the world's largest melanoma specialty centers—where he developed expertise in rare tumors. He then completed a second fellowship in Mohs micrographic surgery and facial reconstruction at Mayo Clinic under Dr. Clark Otley, receiving specialized transplant dermatology training.


Dr. Hocker has performed over 23,000 Mohs surgery cases and serves as founding division chief of dermatologic surgery at the University of Missouri-Kansas City and University Health. He is an active member of the International Transplant Skin Cancer Collaborative (ITSCC) and will be a key lecturer at the 2026 American College of Mohs Surgery national meeting.


He has been recognized as a Castle Connolly Top Doctor (2024, 2025) and received the Ingram's Top Doctor Award in 2025.

Skin Cancer
By ADS Press Release February 25, 2026
Organ transplant recipients face a dramatically higher risk of skin cancer. Learn why early detection and expert care matter.
Microscope on a lab countertop, second microscope blurred in background.
By ADS Press Release February 18, 2026
Learn why squamous cell carcinoma becomes the most dangerous skin cancer for transplant recipients and how expert care helps.